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Clinical Infectious Diseases
Major Article
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Background. Between 2008 and 2018, persons granted asylum (asylees) increased by 168% in the United States. Asylees are eligible
for many of the same domestic benefits as refugees under the US Refugee Admissions Program (USRAP), including health-related benefits
such as the domestic medical examination. However, little is known about the health of asylees to guide clinical practice.
Methods. We conducted a retrospective cross-sectional analysis of domestic medical examination data from 9 US sites from 2014 to
2016. We describe and compare demographics and prevalence of several infectious diseases such as latent tuberculosis infection (LTBI),
hepatitis B and C virus (HBV, HCV), and select sexually transmitted infections and parasites by refugee or asylee visa status.
Results. The leading nationalities for all asylees were China (24%) and Iraq (10%), while the leading nationalities for refugees
were Burma (24%) and Iraq (19 %). Approximately 15% of asylees were diagnosed with LTBI, and 52% of asylee adults were susceptible to HBV infection. Prevalence of LTBI (prevalence ratio [PR] = 0.8), hepatitis B (0.7), hepatitis C (0.5), and Strongyloides (0.5)
infections were significantly lower among asylees than refugees. Prevalence of other reported conditions did not differ by visa status.
Conclusions. Compared to refugees, asylees included in our dataset were less likely to be infected with some infectious diseases but had
similar prevalence of other reported conditions. The Centers for Disease Control and Prevention’s Guidance for the US Domestic Medical
Examination for Newly Arrived Refugees can also assist clinicians in the care of asylees during the routine domestic medical examination.
Keywords. asylees; asylum seekers; refugees; domestic medical examination; health screening.
Refugees and asylees are persons who are outside their countries of nationality and who are unable to return to their countries of nationality because of persecution or a well-founded fear
of persecution on account of race, religion, nationality, membership in a particular social group, or political opinion [1, 2].
Applicants for refugee status are outside their host country and
are typically planned migrations, whereas applicants seeking
asylum are already present in their host country or are seeking
admission at a port of entry [2].
In 2018, the number of persons granted asylum (now asylees)
(38 687) surpassed the number of refugee arrivals (22 405)
for the first time since 2003 [2]. This was likely related to the
steady reduction in planned US refugee admissions since 2016.
Countries of origin for individuals granted asylum and refugees vary each year. In 2014, the leading countries of origin for

Received 20 January 2021; editorial decision 20 May 2021; published online 27 May 2021.
Correspondence: G. S. Kumar, MD, Centers for Disease Control and Prevention, 1600 Clifton
Rd NE, Atlanta, GA 30329 (wiz3@cdc.gov).
Clinical Infectious Diseases®  2021;73(8):1492–9
Published by Oxford University Press for the Infectious Diseases Society of America 2021. This
work is written by (a) US Government employee(s) and is in the public domain in the US.
DOI: 10.1093/cid/ciab502

1492 • cid 2021:73 (15 October) • Kumar et al

asylees were China (35.0%) and Egypt (10.1%) [3], whereas in
2018, the leading countries were China (17.8%) and Venezuela
(15.7%) [2]. In contrast, the leading countries of origin for refugees resettling in the United States from 2008 to 2018 included
Burma, Iraq, Bhutan, Somalia, and Democratic Republic of the
Congo [4].
Refugees and other immigrants receive a medical screening
exam overseas according to the Technical Instructions written
by the US Centers for Disease Control and Prevention (CDC)
[5] and have access to overseas health interventions, such as
vaccines or parasite treatments before departure to the United
States [6]. However, asylees do not receive an overseas medical
screening exam or access overseas health interventions because
they seek asylum after US arrival. After being granted asylum,
asylees are eligible for many of the same domestic benefits as
refugees under the US Refugee Admissions Program (USRAP),
including health-related benefits in the United States [7, 8].
The CDC recommends that asylees receive a domestic
medical examination soon after being granted asylum status
[9]. Refugees are recommended to receive the examination
within 90 days after arrival in the United States [9]. Clinicians
conducting the domestic medical examination for asylees
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Health of Asylees Compared to Refugees in the United
States Using Domestic Medical Examination Data, 2014–
2016: A Cross-Sectional Analysis

METHODS
Analysis Design, Participants, and Setting

A cross-sectional analysis was conducted to examine the prevalence of medical conditions among asylees compared to refugees during the domestic medical examination. Participants
included asylee and refugee adults (≥18 years old) and children
and adolescents (<18 years old) who received a domestic medical examination in the United States between January 2014
and December 2016. Sites were not able to provide information about whether asylees were principal asylees or derivative
asylees. CDC collaborated with 7 states (California, Colorado,
Minnesota, New York, Kentucky, Illinois, and Texas), 1 county
(Marion County, Indiana), and 1 academic medical center in
Philadelphia, Pennsylvania, to collect domestic medical examination data for analysis. These sites provided their data as
part of a CDC-funded nonresearch cooperative agreement.
Although this was a convenience sample, the data set includes
data from 3 states (California, Texas, and New York) with the
highest volume of refugee and/or asylee arrivals between 2014
and 2016. Further details about partners and methodology can
be found elsewhere [14, 15]. This project was reviewed in accordance with CDC institutional review policies and procedures and was determined to be nonresearch.

Data Sources

Each site collected domestic medical examination data, including basic demographic information, anthropometric measurements (ie, body measurements for assessing growth and
body fat distribution), and results of laboratory testing. CDC
guidance recommend screening for both communicable (eg,
tuberculosis [TB] and hepatitis B) and noncommunicable (eg,
elevated blood lead levels) conditions during the domestic
medical examination [10]. Details on diagnosis and categorization of each condition are described further in Tables 2 and 3.
Measures

Demographic information provided included sex, age, nationality, and primary language spoken by the applicant or
used by an interpreter. We examined the results of laboratory testing for tuberculosis, hepatitis B, hepatitis C, malaria,
strongyloidiasis, schistosomiasis, other pathogenic intestinal
parasites, syphilis, chlamydia, and human immunodeficiency virus (HIV); most outcomes were categorized as either “screened and positive” or “screened and negative.” For
hepatitis B, we also analyzed the proportion of individuals
who were susceptible to hepatitis B (ie, at risk for infection
with hepatitis B), where the results of hepatitis B surface antigen (HBsAg), hepatitis B core antibody (anti-HBc), and
hepatitis B surface antibody (anti-HBs) were all negative
(further details on how we categorized hepatitis B status are
outlined in Table 2). During the period of data collection,
CDC guidance recommended screening blood for lead in
children aged six months to 16 years, with elevated blood
lead levels [EBLL] defined as ≥ 5 mcg/dL [10]. For most
conditions, we were unable to collect detailed information
on the method of screening (ie, type of test) used by sites.
Persons who were not screened, or those who were screened
but whose results were unknown, were excluded from the
outcomes analysis.
Statistical Methods

Frequencies and proportions were calculated to describe demographic characteristics and prevalence of medical conditions;
results were stratified by asylee or refugee status and age at
screening visit (adult ≥ 18 years, child < 18 years). We used χ 2
tests or Fisher exact tests to compare each medical condition
by refugee/asylee status. Fisher exact tests were used if the frequency per cell was <5. Statistical significance was noted at a
P value < .05. Denominators for medical conditions varied because of missing data and screening differences across sites.
A modified Poisson regression was used to model the adjusted prevalence ratio (adjusting for age and sex) while accounting for state-level clustering. Status at entry (refugee status
as reference) was the primary exposure variable, and select medical conditions (ie, latent tuberculosis infection [LTBI], hepatitis B virus [HBV], hepatitis C virus [HCV], strongyloidiasis,
Health of Asylees in the United States • cid 2021:73 (15 October) • 1493
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have been encouraged to follow CDC’s Guidance for the US
Domestic Medical Examination for Newly Arrived Refugees
[10]. Because the CDC guidance were originally developed
for refugee populations, reporting on the guidelines’ effectiveness in capturing health conditions among asylee populations is limited [10]. Minimal information about the health
of asylees exists in the literature [11–13]. Increasing clinician
knowledge about common health conditions encountered in
asylees may facilitate diagnostic screening, targeted clinical
evaluation, and referrals to additional healthcare providers
in the United States. In addition, more data are needed comparing the health of asylees and refugees given the potential similarities in reasons for US resettlement and because
both populations are eligible to receive the domestic medical
examination. However, differences due to countries of origin and conditions of emigration or transit likely exist between these 2 populations and can contribute to differences
in risks of disease exposure. Assessing differences in health
profiles between these populations can inform clinical management and whether public health interventions, including
domestic medical examination guidance, should be tailored
to specific groups.
Therefore, the purpose(s) of this analysis are 2-fold: 1) describe the frequency and prevalence of screened medical conditions among asylees during the domestic medical examination
and 2) compare the prevalence of medical conditions in asylees
and refugees during domestic medical examinations.

schistosomiasis, and elevated blood lead levels [EBLL]) were the
primary outcome variables. We excluded medical conditions
with 5 or fewer cases or that were not statistically significant in
the bivariate analysis (Table 2).
RESULTS

Table 1.

The proportion of all asylees who were not screened for a
particular medical condition were as follows: LTBI (6%);
HBV (2%); HCV (32%); malaria (50%); strongyloidiasis
(81%); schistosomiasis (95%); other intestinal parasites
(21%); syphilis (22%); chlamydia (80%); HIV (7%); and elevated blood lead level (children only: 22%). The proportion
of refugees who were not screened for a particular medical
condition and any differences in proportions screened for
a medical condition by visa status have been reported elsewhere [14].
Adults

Overall, 1787 (84%; 95% confidence interval [CI]: .83–.86)
asylee adults (vs 76% [95% CI: .75–.76] of refugee adults) had
no evidence of tuberculosis infection, and 15% (vs 22%) were
diagnosed with LTBI (Table 2). Approximately 52% (95%
CI: .50–.53) of asylee adults were susceptible to HBV infection compared to 40% (95% CI: .40–.41) of refugee adults
(Table 2). In the adjusted analysis, there were no differences
in status of susceptibility to HBV infection between asylees

Demographic Characteristics of Asylees and Refugees Who Resettled to the United States, 2014–2016
All

Demographic Characteristics
Total

Asylee n (%)
4044

Adults ≥18 years old
Refugee n (%)
74 018

Asylee n (%)
2901

Refugee n (%)
45 113

Children <18 years old
Asylee n (%)
1143

Refugee n (%)
28 905

Sexa
Female

1933 (47.8)

35 973 (48.6)

1390 (47.9)

21 882 (48.5)

543 (47.5)

14 091 (48.8)

Male

2111 (52.2)

38 033 (51.4)

1511 (52.1)

23 226 (51.5)

600 (52.5)

14 807 (51.2)

Age, ya
0–2

92 (8.1)

5081 (17.6)

3–5

203 (17.8)

5697 (19.7)

848 (74.2)

18 127 (62.7)

6–17
18–44

2267 (78.2)

45–64

552 (19.0)

8258 (18.3)

82 (2.8)

2347 (5.2)

≥65

34 508 (76.5)

Nationality
China

950 (23.5)

Iraq

389 (9.6)

14 170 (19.1)

132 (0.2)

645 (22.2)

94 (0.2)

305 (26.7)

323 (11.1)

9368 (20.8)

66 (5.8)

4802 (16.6)

38 (0.1)

319 (11.0)

5488 (12.2)

48 (4.2)

904 (3.1)

Iran

367 (9.1)

6392 (8.6)

Egypt

337 (8.3)

60 (0.8)

204 (7.0)

Ethiopia

208 (5.1)

905 (1.2)

150 (5.2)

Afghanistan

191 (4.7)

2396 (3.2)

104 (3.6)

1407 (3.1)

87 (7.6)

989 (3.4)

Syria

190 (4.7)

4136 (5.6)

134 (4.6)

1873 (4.2)

56 (4.9)

2263 (7.8)
128 (0.4)

27 (0.06)
530 (1.2)

133 (11.6)

33 (0.1)

58 (5.1)

375 (1.3)

Nepal

173 (4.3)

288 (0.4)

113 (3.9)

160 (0.4)

60 (5.3)

Eritrea

154 (3.8)

950 (1.3)

133 (4.6)

526 (1.2)

21 (1.8)

424 (1.5)

Somalia

110 (2.7)

8288 (11.2)

101 (3.5)

4332 (9.6)

9 (0.8)

3956 (13.7)

Burma

29 (0.7)

17 674 (23.9)

19 (0.7)

10 764 (23.9)

10 (0.9)

6910 (23.9)

Democratic Republic of the Congo

28 (0.7)

6387 (8.6)

18 (0.6)

3074 (6.8)

10 (0.9)

3313 (11.5)

Ukraine

6 (0.2)

167 (0.2)

6 (0.2)

108 (0.2)

Bhutan

6 (0.2)

4200 (5.7)

4 (0.1)

2938 (6.5)

2 (0.2)

1262 (4.4)

906 (22.4)

7873 (10.6)

4424 (9.8)

278 (24.3)

3449 (11.9)

Other nationalities

628 (21.7)

Percentages may not add up to 100% because of rounding.
Abbreviation: SD, standard deviation.
a

Number missing: Sex (n = 5 for refugee adults and n = 7 for refugee children); age (n = 7 for refugee children).
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Of the 78 062 individuals included in our analysis, 4044 (5%)
were asylees and 74 018 (95%) were refugees (Table 1). Among
the 4044 asylees, there were 2901 adults and 1143 children. The
median age for refugees was 23 years (interquartile range [IQR]:
10–36), and the median age for asylees was 27 years (IQR:
16–38). There were 88 nationalities represented by asylees, and
82 primary languages spoken by or used by an interpreter. There
were 115 nationalities represented by refugees. The leading nationalities for all asylees were China (24%), Iraq (10%), and Iran
(9%), whereas the leading nationalities for refugees were Burma
(24%), Iraq (19 %), and Somalia (11%). Both asylee and refugee
populations had 6 nationalities in common (Iraq, Iran, Somalia,
Syria, Afghanistan, and Eritrea) among the top 10 nationalities
represented by both populations.

Asylees Not Screened for a Particular Condition

Table 2.

Domestic Medical Examination Results Among Asylees and Refugees Who Resettled to the United States, 2014–2016
Adults ≥ 18 years old

Medical Screening Characteristic

Children < 18 years old

Asylee n (%)

Refugee n (%)

P value

Asylee n (%)

Refugee n (%)

P value

<.0001

<.0001

Total
Tuberculosisa

n = 28 350

n = 822

n = 17 193

1787 (84.2)

21 526 (75.9)

783 (95.3)

15 654 (91.1)

Clinically active

1 (0.1)

54 (0.2)

0

14 (0.1)

Not clinically active

10 (0.5)

423 (1.5)

0

88 (0.51)

Latent tuberculosis infection

325 (15.3)

6347 (22.4)

39 (4.7)

1437 (8.4)

n = 2757

n = 42 770

n = 1040

n = 25 955

Susceptible

1422 (51.6)

17 172 (40.2)

286 (27.5)

6346 (24.5)

Uninfected, susceptibility unknown

304 (11.0)

6892 (16.3)

308 (29.6)

8081 (31.1)

Infected

75 (2.7)

1579 (3.7)

7 (0.7)

351 (1.3)

  Natural infection

266 (9.7)

4832 (11.3)

12 (1.2)

458 (1.8)

   Hepatitis B vaccination

663 (24.1)

10 395 (24.3)

423 (40.7)

10 363 (39.9)

  Not specified

27 (1.0)

1810 (4.2)

4 (0.4)

356 (1.4)

Hepatitis Cc

n = 2065

n = 24 603

n = 698

n = 11 320

26 (1.3)

561 (2.3)

2 (0.3)

81 (0.7)

n = 1491

n = 7582

n = 518

n = 3252

3 (0.2)

13 (0.2)

0

29 (0.9)

n = 581

n = 8724

n = 192

n = 6890

11 (1.9)

331 (3.8)

2 (1.0)

83 (1.2)

n = 143

n = 4306

n = 41

n = 4135

20 (14.0)

303 (7.0)

1 (2.4)

128 (3.1)

n = 2286

n = 21 139

n = 907

n = 13 164

7 (0.31)

50 (0.24)

7 (0.77)

98 (0.74)

n = 2609

n = 31 270

n = 527

n = 5960

23 (0.9)

294 (0.9)

2 (0.4)

26 (0.4)

n = 631

n = 8363

n = 160

n = 1823

18 (2.9)

150 (1.8)

2 (1.3)

19 (1.0)

n = 2771

n = 36 365

n = 1003

n = 19 969

27 (1.0)

283 (0.8)

1 (0.1)

47 (0.2)

n = 845

n = 24 757

<5

N/A

N/A

787 (93.1)

21 709 (87.7)

5–9

N/A

N/A

52 (6.2)

2707 (10.9)

10–19

N/A

N/A

6 (0.7)

293 (1.2)

20–44

N/A

N/A

0

43 (0.1)

45–70

N/A

N/A

0

5 (0.02)

Hepatitis Bb

<.0001

.004

Immune

Screened, positive
Malariad
Screened, positive
Strongyloidiasise
Screened, positive
Schistosomiasise
Screened, positive
Pathogenic intestinal parasitesf
Screened, positive
Syphilisg
Screened, positive
Chlamydiag
Screened, positive
HIVg
Positive, screened/unscreened (type 1, type 2, or unknown)
Blood lead level (mcg/dL)h

.002
.74
.02
.02
.52
.83
.07
.26

.24
.03
1.0
1.0
.93
1.0
.69
.73
<.0001

2

Percentages may not add up to 100% because of rounding. We used χ or Fisher exact tests to compare characteristic or disease condition by status at entry (asylee vs refugee). Fisher
exact tests were used if frequency per cell was < 5. Statistical significance was noted at a P value < .05. Proportion of all asylees who were not screened for a particular medical condition:
latent tuberculosis infection (6%); hepatitis B virus (2%); hepatitis C virus (32%); malaria (50%); strongyloides (81%); schistosomiasis (95%); other intestinal parasites (21%); syphilis (22%);
chlamydia (80%); human immunodeficiency virus (HIV) (7%); and elevated blood lead level (children only: 22%).
Abbreviations: HBc, hepatitis B core antibody; HBs, hepatitis B surface antibody; HBsAg, hepatitis B surface antigen; N/A, not applicable.
a

For tuberculosis (TB), information on diagnosis was reported and categorized as no evidence of TB, clinically active, not clinically active and latent tuberculosis infection (LTBI) [25]. TB disease diagnosis was made by a positive smear, culture, or clinical diagnosis of pulmonary TB. A classification of not clinically active TB was made when a person had a history of previous
episode(s) of TB or abnormal stable radiographic findings and had a positive reaction to tuberculin skin test (TST), negative cultures, and no clinical and/or radiographic evidence of current disease. Diagnosis of LTBI was made by a positive interferon gamma release assay (IGRA) or TST and negative diagnostic workup for TB. The majority of asylee adults (99%) were tested using
IGRA. Among children tested for LTBI, 92% were tested using IGRA and 8% were tested using TST. Data were included if states provided information about TB diagnosis for an individual.
b
Hepatitis B virus status was categorized as susceptible (HBsAg, anti-HBc, and anti-HBs all negative), uninfected/susceptibility unknown (HBsAg negative, anti-HBc and anti-HBs unknown),
infected (HBsAg positive), immune through natural infection (HBsAg negative, anti-HBc positive and anti-HBs positive), immune through hepatitis B vaccination (HBsAg negative, anti-HBc
negative, and anti-HBs positive) and immune but not specified (HBsAg negative, anti-HBs positive and anti-HBc unknown) [26].
c

Hepatitis C was diagnosed by any of the following: detection of antibody to hepatitis C virus (anti-HCV), a positive recombinant immunoblot assay (RIBA) result, or a positive HCV RNA
polymerase chain reaction (PCR) result.
d

Malaria diagnosis was laboratory-confirmed using either microscopy or by a rapid diagnostic test.

e

Strongyloides and schistosomiasis diagnoses were laboratory-confirmed using either microscopy or by serology testing.

f

Intestinal parasite infection diagnoses were laboratory-confirmed using stool ova and parasite testing.

g
Syphilis diagnosis was made via a positive nontreponemal test (Venereal Disease Research Laboratory [VDRL] or rapid plasma reagin [RPR]) followed by a positive confirmatory treponemal
test (eg, Treponema pallidum-particle agglutination [TP-PA], microhemagglutination assay for Treponema pallidum [MHA-TP]). Syphilis testing is recommended in all persons ≥15 years of age
if no overseas testing results are available, and in persons <15 years of age if sexually active. Chlamydia and HIV diagnoses were made via laboratory-confirmed testing.
h

Blood lead level screening applies to children from 6 months up to 16 years of age only.
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n = 2123

No evidence of tuberculosis

Children

Overall, 783 (95%; 95% CI: .94–.97) asylee children (vs 91%
[95% CI: .91–.92] of refugee children) had no evidence of tuberculosis infection, and 5% (95% CI: .03–.06) (vs 8% [95% CI:
.08–.09] of refugee children) had a diagnosis of LTBI (Table 2).
Asylee children were less likely to have LTBI compared to refugee children (PR: 0.7; 95% CI: .5–.96). About 28% of asylee
children (vs 25% of refugee children) were susceptible to HBV
infection, although this proportion may differ given that 30%
of asylees were uninfected, with their susceptibility unknown.
Approximately 0.7% (95% CI: .003–.012) of asylees (vs 1% [95%
CI: .012–.015] of refugees) were HBV-infected, whereas 42%
(95% CI: .37–.43) were immune (vs 43% [95% CI: .42–.44]).
Compared to refugees, asylees were less likely to be infected
with HBV (PR: 0.4; 95% CI: .2–.8). Approximately 7% (95%
CI: .05–.09) of asylees (vs 12% [95% CI: .12–.13]) had EBLL.

Table 3.

In adjusted analysis, there was no difference in the prevalence
of HCV, strongyloidiasis, schistosomiasis, other pathogenic intestinal parasites, syphilis, chlamydia, HIV, and EBLL between
asylee and refugee children who were screened for each condition (Table 3).

DISCUSSION

In our analysis, about 15% of adult asylees were diagnosed with
LTBI, as compared to 22% of adult refugees. About half of asylee
adults and over a quarter of asylee children were susceptible
to HBV infection. When compared to refugee adults, asylee
adults were less likely to be infected with LTBI, HBV, HCV, and
Strongyloides but had similar prevalence of other reported conditions, such as other pathogenic intestinal parasites. Compared
to refugee children, asylee children were less likely to have LTBI
or HBV infection but had a similar prevalence of other reported
conditions. The majority of asylees who received a domestic
medical examination between 2014 and 2016 were from China,
Iraq, and Iran.
Few published studies exist describing the physical health
profile of asylee populations in the United States [11–13, 16], although it is possible that asylees were included in other studies
of newcomer populations, but not specifically identified. To the
authors’ knowledge, this is one of few analyses among asylee
populations in the United States that reports screening data for
most of the conditions screened as part of the domestic medical
examination. In contrast to other published studies, our analysis included data from multiple sites across the country.
Prevalence of reported communicable diseases among
asylees varied across studies with LTBI ranging from 5% to 41%
[11–13], and HBV infection ranging from 2% to 9% [11, 12].
Differences in estimates between our analysis and other studies

Adjusted Prevalence Ratios for Select Medical Conditions Among Asylees and Refugees Who Resettled to the United States, 2014–2016

Medical Conditions

All

Adults ≥18 years old

Children <18 years old

aPR (95% CI) Ref: Refugee

aPR (95% CI) Ref: Refugee

aPR (95% CI) Ref: Refugee

0.76 (.62–.94)

0.76 (.63–.94)

0.70 (.52–.96)

Latent tuberculosis infection
Hepatitis Ba
Susceptible

1.19 (.93–1.52)

1.21 (.93–1.57)

1.08 (.85–1.36)

Infected

0.73 (.55–.98)

0.72 (.54–.97)

0.43 (.23–.83)

Immune through vaccination

0.89 (.73–1.09)

0.83 (.60–1.16)

0.97 (.85–1.11)

Hepatitis C

0.54 (.46–.63)

0.56 (.46–.67)

0.38 (.14–1.04)

Strongyloides

0.53 (.36–.80)

0.50 (.33–.75)

0.79 (.50–1.26)

Schistosomiasis

2.06 (1.01–4.20)

1.88 (.99–3.57)

Elevated blood lead level (≥ 5 mcg/dL)

N/A

N/A

…
0.6 (.3–1.1)

Poisson regression was used to model the adjusted prevalence ratios (adjusted for age and sex) to assess association of status at entry (asylee vs. refugees) and outcomes. Refugee status
was used as reference.
Abbreviations: aPR, adjusted prevalence ratio; CI, confidence interval; HBc, hepatitis B core antibody; HBs, hepatitis B surface antibody; HBsAg, hepatitis B surface antigen; N/A, not
applicable.
a
Hepatitis B virus status was categorized as susceptible (HBsAg, anti-HBc, and anti-HBs all negative), infected (HBsAg positive), and immune through hepatitis B vaccination (HBsAg negative, anti-HBc negative, and anti-HBs positive).

1496 • cid 2021:73 (15 October) • Kumar et al

Downloaded from https://academic.oup.com/cid/article/73/8/1492/6287100 by Thomas Jefferson University user on 14 December 2021

and refugees. However, another 11% of asylee adults and 16%
of refugee adults had unknown susceptibility to HBV (ie,
HBsAg negative, status of anti-HBc and anti-HBs unknown);
therefore, the proportion of each population susceptible to
hepatitis B may differ. Compared to refugees, asylees were
less likely to have LTBI (prevalence ratio [PR]: 0.8; 95% CI:
.6–.9), HBV (PR: 0.7; 95% CI: .5–.97), HCV (PR: 0.56; 95%
CI: .5–.7), and Strongyloides infection (PR: 0.5; 95% CI: .3–.8)
in the adjusted analysis (Table 3). Although a greater proportion of asylee adults screened positive for schistosomiasis
(PR: 14%; 95% CI: .08–.20) compared to refugee adults (PR:
7%; 95% CI: .06–.08), there were no differences in the prevalence of schistosomiasis in the adjusted analysis. There were
no differences in the prevalence of malaria, other pathogenic
intestinal parasites, syphilis, chlamydia, and HIV between
asylees and refugees.

clinicians should strongly consider screening and treating for
intestinal parasites, including strongyloidiasis and schistosomiasis, according to CDC guidance, to prevent further transmission or complications.
Of note, although the leading nationalities of asylee populations who received a domestic medical examination and were
included in our analysis were China, Iraq, and Iran, the leading
nationalities of all persons granted asylum between 2014 and
2016 were China (22–34%), Egypt (12%), and El Salvador
(8–11%). Therefore, our findings may not be representative of
the characteristics of all asylee populations over the time period
[20]. It is possible that asylees of other nationalities did not reside in the states included in our analysis or were not captured
in the data set, even if they received a domestic medical examination [21]. It is also possible that asylees of other nationalities did not access or minimally accessed healthcare benefits
or services. Many asylees may be unaware that they are eligible
for healthcare benefits, including the domestic medical examination, or how to access health services and other benefits upon
being granted asylum [7, 8]. Language barriers and social exclusion or discrimination by members of their own or other communities may also prevent asylees from accessing benefits and
services [22]. Some asylees may have already accessed healthcare if they have been present in the United States for some
time before being granted asylum [19]. Therefore, greater outreach to individuals who were recently granted asylum could be
conducted to improve awareness of benefits and identify and
resolve access barriers. These efforts may require collaboration across different entities, including legal organizations processing asylum cases, resettlement agencies, the US Citizenship
and Immigration Services, community-based organizations
working with asylum seeker populations, and state refugee
health programs. Outreach efforts may include providing information regarding healthcare services and providers when
individuals are awarded asylum status. Groups conducting outreach to asylee populations can emphasize messaging such as
how the domestic medical examination is an opportunity for
earlier identification and management of conditions not typically screened for during a routine primary care visit.
Limitations

This analysis has several limitations. First, health screening data
were not collected and reported uniformly across all 9 sites;
therefore, denominators across medical conditions and diagnoses varied. Generally, although screening and testing were
conducted according to CDC guidance, variation by location
existed, as the guidance are meant to be customized in each
jurisdiction. Second, the CDC domestic medical examination
guidance [10] differentiate screening according to nationality,
age of patient, and availability of overseas health records; thus,
not all tests were conducted for all asylees and refugees. These
could be reasons why many asylees were not screened for some
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could be related to sample size, the definition of “asylee” used
(eg, not differentiating between asylum-seekers and asylees
or primary and derivative asylees), nationalities of asylees receiving a health examination during the time period of the
study, and the average duration of US residence of asylees. For
example, disease exposures in countries with high incidence or
prevalence of conditions, such as tuberculosis disease and HBV
infection before emigration or during transit and the availability of and accessibility to vaccination programs and health
care before and after journey to the United States can influence
the presence of some health conditions among asylees [17, 18].
Asylees in our analysis had either a lower or similar prevalence of reported conditions (eg, similar prevalence of pathogenic intestinal parasites) compared to refugees. Asylees
also had a similar susceptibility to HBV infection. This is
despite refugees having access to the overseas presumptive
parasite treatment program and the voluntary Vaccination
Program for US-bound Refugees, which was created to provide 1–2 doses of certain vaccines overseas (including hepatitis B vaccine) [6]; however, both of these programs were
still in the early stages of global expansion during the data
collection period, and hence the current picture may differ.
These results are consistent with findings in a smaller study
comparing prevalence of certain conditions between asylees
and refugees from 2003 to 2007, including tuberculosis and
HBV infection [11]. Differences between asylees and refugees could be due in part to the different prevalence of/risk of
exposure to certain conditions, such as hepatitis B, intestinal
parasites, and tuberculosis, in the countries of emigration
or transit and availability and access to clinical and preventive health services prior to or after US arrival (in the case
of asylees). Principal asylees who have been present in the
United States for any significant period of time—because the
length of the asylum process can vary between 6 months and
several years [19]—may have had access to healthcare services [12], and it is possible that any identified health conditions and vaccinations were addressed before the domestic
medical examination.
Given the potentially serious outcomes of some medical
conditions identified during the domestic medical examination (such as tuberculosis and HBV infection) if not evaluated
and managed promptly, US clinicians should refer to CDC’s
Guidance for the US Domestic Medical Examination for Newly
Arrived Refugees to screen for and manage conditions found
in asylees and offer vaccinations to those without laboratory
evidence or a historical record of vaccination for conditions
such as HBV infection [10]. Because asylees do not receive
predeparture presumptive parasite treatment, and because the
majority of asylees did not receive screening for strongyloidiasis and schistosomiasis (although it is possible some asylees
were not recommended for screening due to countries of origin or transit or were presumptively treated after arrival), US

healthcare and accessing benefits. It may also be valuable to
repeat our analysis every few years, given the changing demographic landscape of asylee populations in the United States.
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CONCLUSION

In our analysis, we observed that 15% of asylees were diagnosed with LTBI and 52% of asylee adults were susceptible
to HBV infection. Compared to refugees, asylees included
in our data set were less likely to be infected with LTBI and
HBV but had similar prevalence of other reported conditions. However, estimates for LTBI and HBV are higher than
for the general US population (US, LTBI: up to 5%; HBV:
<2%) [23, 24]. Therefore, in addition to guiding screening for
refugees, CDC domestic medical examination guidance can
also assist refugee health programs and clinicians in the care
of asylees during the routine domestic medical examination
[10]. Based on the results of this analysis, clinicians should
ensure that asylees receive the appropriate screening procedures and follow up (including vaccines) as indicated, paying
attention to conditions such as LTBI, HBV, and, among children, EBLL. With the help of community and public health
partners, greater outreach to asylees when asylum status is
awarded and ongoing communication after being granted
asylum may be needed to ensure awareness of available benefits and identify and resolve barriers to accessing benefits,
including the domestic medical examination. Future analyses
can explore other aspects of health among asylee populations, including noncommunicable diseases and vaccination
coverage, as well as identify any existing barriers to receiving
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